Werewolf Therapeutics Inc
NASDAQ:HOWL

Watchlist Manager
Werewolf Therapeutics Inc Logo
Werewolf Therapeutics Inc
NASDAQ:HOWL
Watchlist
Price: 2.05 USD -4.65%
Market Cap: 89.6m USD
Have any thoughts about
Werewolf Therapeutics Inc?
Write Note

Werewolf Therapeutics Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Werewolf Therapeutics Inc
Total Liabilities & Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Werewolf Therapeutics Inc
NASDAQ:HOWL
Total Liabilities & Equity
$174.8m
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Liabilities & Equity
$143.4B
CAGR 3-Years
-1%
CAGR 5-Years
19%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities & Equity
$54.5B
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Total Liabilities & Equity
$90.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities & Equity
$22.2B
CAGR 3-Years
21%
CAGR 5-Years
24%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities & Equity
$37.4B
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Werewolf Therapeutics Inc's Total Liabilities & Equity?
Total Liabilities & Equity
174.8m USD

Based on the financial report for Dec 31, 2023, Werewolf Therapeutics Inc's Total Liabilities & Equity amounts to 174.8m USD.

What is Werewolf Therapeutics Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
22%

Over the last year, the Total Liabilities & Equity growth was 9%. The average annual Total Liabilities & Equity growth rates for Werewolf Therapeutics Inc have been 22% over the past three years .

Back to Top